Summary

• HSE and System C are rolling out CareFlow Pharmacy across public hospitals in Ireland.
• Nine hospitals are live, 12 more are due in 2026, and 34 further deployments are planned.
• The rollout shows public health technology moving from local digitisation to national operational infrastructure.

System C and Ireland’s Health Service Executive have agreed a national rollout of CareFlow Pharmacy across public hospitals in the Republic of Ireland.

The programme has nine hospitals live, a further 12 expected during 2026, and another 34 hospitals planned in a later phase. The agreement follows deployment work through 2025 and supports the HSE’s goal of digitising and standardising pharmacy services.

Hospital pharmacy systems are not usually the most visible part of health technology, although they sit close to patient safety, clinical workflow, inventory control, and financial management. Medicines errors, stock shortages, duplicated work, and fragmented data all create pressure in health systems already struggling with capacity and staffing.

A national pharmacy platform gives Ireland a route to more consistent medicines management across public hospitals. The operational value will depend on whether the system improves visibility over stock, prescribing, dispensing, and medication governance in daily clinical use. It also creates a foundation for better data on medicines activity, which can support planning, audit, procurement, and safety monitoring.

Health technology projects often stall at the boundary between local deployment and system-wide adoption. Single-site digitisation can produce useful gains, but wider value appears when processes, data structures, and governance are standardised across multiple organisations. Ireland’s approach suggests a move toward common infrastructure rather than a collection of disconnected hospital systems.

Implementation will still be difficult. Pharmacy systems must fit into clinical routines, electronic health records, prescribing processes, procurement systems, and local operational practices. Hospitals differ in size, staffing, workflows, and legacy technology. National consistency can improve governance, but it can also run into local complexity if deployment is treated as a software installation rather than a service redesign.

The supplier relationship is also worth close attention. System C is a UK-headquartered health and social care technology provider, and Ireland’s national deployment gives it a substantial public sector reference point as health systems across Europe digitise core operational processes. For HSE, the test is whether a national vendor-led system can produce measurable improvement in safety, efficiency, and staff workload.

Health technology markets are crowded with ambitious claims about AI and patient-facing apps, but pharmacy digitisation is a reminder that much of the hard work lies in core infrastructure. Medicines management touches every hospital ward, and small process failures can have serious clinical consequences.

Ireland’s CareFlow rollout should be judged on adoption by pharmacists and clinicians, integration with existing systems, reduction in manual work, inventory accuracy, and patient safety outcomes. A national platform may not be glamorous, but it can be more consequential than many front-end digital products.